These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1131 related articles for article (PubMed ID: 19224838)
21. Improved survival of patients with hepatocellular carcinoma and disparities by age, race, and socioeconomic status by decade, 1983-2012. Wang S; Sun H; Xie Z; Li J; Hong G; Li D; Mallampati S; Zhou X; Zhou C; Zhang H; Cheng Z; Shan H; Ma H Oncotarget; 2016 Sep; 7(37):59820-59833. PubMed ID: 27486977 [TBL] [Abstract][Full Text] [Related]
22. Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer. Ryerson AB; Eheman CR; Altekruse SF; Ward JW; Jemal A; Sherman RL; Henley SJ; Holtzman D; Lake A; Noone AM; Anderson RN; Ma J; Ly KN; Cronin KA; Penberthy L; Kohler BA Cancer; 2016 May; 122(9):1312-37. PubMed ID: 26959385 [TBL] [Abstract][Full Text] [Related]
23. Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030. Petrick JL; Kelly SP; Altekruse SF; McGlynn KA; Rosenberg PS J Clin Oncol; 2016 May; 34(15):1787-94. PubMed ID: 27044939 [TBL] [Abstract][Full Text] [Related]
24. Texas Has the Highest Hepatocellular Carcinoma Incidence Rates in the USA. El-Serag HB; Sardell R; Thrift AP; Kanwal F; Miller P Dig Dis Sci; 2021 Mar; 66(3):912-916. PubMed ID: 32303951 [TBL] [Abstract][Full Text] [Related]
25. Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival. Sloane D; Chen H; Howell C J Natl Med Assoc; 2006 Dec; 98(12):1934-9. PubMed ID: 17225837 [TBL] [Abstract][Full Text] [Related]
26. Geographic variation within the United States in the incidence of hepatocellular carcinoma. Davila JA; Petersena NJ; Nelson HA; El-Serag HB J Clin Epidemiol; 2003 May; 56(5):487-93. PubMed ID: 12812824 [TBL] [Abstract][Full Text] [Related]
27. Striking Racial/Ethnic Disparities in Liver Cancer Incidence Rates and Temporal Trends in California, 1988-2012. Pham C; Fong TL; Zhang J; Liu L J Natl Cancer Inst; 2018 Nov; 110(11):1259-1269. PubMed ID: 29617913 [TBL] [Abstract][Full Text] [Related]
28. Decreasing incidence of hepatocellular carcinoma among most racial groups: SEER-22, 2000-2019. O'Brien TR; Devesa SS; Koshiol J; Marrero JA; Shiels MS Cancer Med; 2023 Oct; 12(19):19960-19967. PubMed ID: 37776201 [TBL] [Abstract][Full Text] [Related]
29. Time-trends in incidence and prognosis of hepatocellular carcinoma in Denmark: A nationwide register-based cohort study. Jepsen P; Andersen MW; Villadsen GE; Ott P; Vilstrup H Liver Int; 2017 Jun; 37(6):871-878. PubMed ID: 27943604 [TBL] [Abstract][Full Text] [Related]
30. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. McGlynn KA; Tarone RE; El-Serag HB Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1198-203. PubMed ID: 16775181 [TBL] [Abstract][Full Text] [Related]
31. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. El-Serag HB; Davila JA; Petersen NJ; McGlynn KA Ann Intern Med; 2003 Nov; 139(10):817-23. PubMed ID: 14623619 [TBL] [Abstract][Full Text] [Related]
32. Impact of sex on the survival of patients with hepatocellular carcinoma: a Surveillance, Epidemiology, and End Results analysis. Yang D; Hanna DL; Usher J; LoCoco J; Chaudhari P; Lenz HJ; Setiawan VW; El-Khoueiry A Cancer; 2014 Dec; 120(23):3707-16. PubMed ID: 25081299 [TBL] [Abstract][Full Text] [Related]
33. Association of nativity with survival among adults with hepatocellular carcinoma. Zhou K; Song Z; Rostomian N; Dodge JL; Stern MC; Setiawan VW; Terrault NA; Cockburn MG; Liu L J Natl Cancer Inst; 2023 Jul; 115(7):861-869. PubMed ID: 37160726 [TBL] [Abstract][Full Text] [Related]
34. Disparities in Hepatocellular Carcinoma Incidence in California: An Update. Sangaramoorthy M; Yang J; DeRouen MC; Ho C; Somsouk M; Tana MM; Thompson CA; Gibbons J; Gomez SL; Shariff-Marco S Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):79-87. PubMed ID: 31719066 [TBL] [Abstract][Full Text] [Related]
35. Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study. Davila JA; El-Serag HB Clin Gastroenterol Hepatol; 2006 Jan; 4(1):104-10; quiz 4-5. PubMed ID: 16431312 [TBL] [Abstract][Full Text] [Related]
36. Incidence and survival of pediatric and adult hepatocellular carcinoma, United States, 2001-2020. Arnett A; Siegel DA; Dai S; Thompson TD; Foster J; di Pierro EJ; Momin B; Lupo PJ; Heczey A Cancer Epidemiol; 2024 Oct; 92():102610. PubMed ID: 38986355 [TBL] [Abstract][Full Text] [Related]
37. Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States. Wong RJ; Corley DA Dig Dis Sci; 2009 Sep; 54(9):2031-9. PubMed ID: 19117131 [TBL] [Abstract][Full Text] [Related]
38. Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976-2005. Gao S; Yang WS; Bray F; Va P; Zhang W; Gao J; Xiang YB Eur J Epidemiol; 2012 Jan; 27(1):39-46. PubMed ID: 22160277 [TBL] [Abstract][Full Text] [Related]
39. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. El-Serag HB; Davila JA Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699 [TBL] [Abstract][Full Text] [Related]
40. National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003. Ahmed F; Perz JF; Kwong S; Jamison PM; Friedman C; Bell BP Prev Chronic Dis; 2008 Jul; 5(3):A74. PubMed ID: 18558024 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]